Back to Authors

Du, Weiming

Mayo Clinic

Alnylam Pharmaceuticals (United States)

Citations 1

Comparison of Patients with Primary Hyperoxaluria 1 and Late-Stage CKD from the BONAPH1DE Registry and ILLUMINATE-C Lumasiran Trial
Baum, Michelle A. , Ben‐Shalom, Efrat , Belostotsky, Vladimir , Sellier-Leclerc, A.L., Du, W. J. , Kauf, Teresa L., Murphy, Michael Desmond, Groothoff, Jaap W. , Lieske, John C. , Knauf, Felix , Sellier‐Leclerc, Anne‐Laure , Du, Weiming, Callanan, Mary B.

Journal of the American Society of Nephrology | December 1, 2025 | Volume: 36 | Issue: 10S | Pages: No page available

10.1681/asn.2025b26anqr1 Get It